22-23 PHARMA - Fast and the curious This month: the NHS as a dystopian game of Tetris, the GLP-1 explosion and its impact on future meds, plus deep dives into AI in pharma, reproductive health, and Trump’s healthcare influence. Also, co...

#mRNAvaccines #GLP1 #obesity #CARTcelltherapies #oncology #PCSK9inhibitors #HepatitisC #Immunotherapy #checkpointinhibitors #RSVvaccines #Genetherapies #rarediseases #antivirals #Biosimilars #expandedaccess #biologics #HIV #Migraine #CGRPinhibitors #antifungals #precisionmedicine
zurl.co/3UDz7

Cell and gene therapies: Stagnation or maturation? Despite questions around stagnation, experts argue that cell and gene therapies are evolving rapidly –driven by innovation in manufacturing, decentralisation, and targeted delivery. Nicole Raleigh gat...

#Cellandgenetherapies #CGTs #CARTs #FDA #cellandgeneandtissuetherapies #CARTcelltherapies #AAV #autologousCARTtherapies #CD19 #BCMA #REMS #celltherapytechnologies #AnthonyNolan #CARTworkflow #Vertex #bluebirdbio #eXmoorPharma #CGTindustry #personalisedtreatment
pharmaphorum.com/deep-dive/ce...

From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy - Journal of Translational Medicine In the past decades, Chimeric Antigen Receptor (CAR)-T cell therapy has achieved remarkable success, leading to the approval of six therapeutic products for haematological malignancies. Recently, the ...

New article provides a fantastic overview of next-gen #InVivo #CARTcellTherapies, delivery systems, mfg process, possible drawbacks, and a future that might include #CARNK and #CARM. #CellandGeneTherapy #CARTcells #CellTherapyManufacturing

translational-medicine.biomedcentral.com/articles/10....